KOD

Kodiak Sciences' stock has experienced significant volatility and notable events in the past six months. The stock saw a substantial surge in March 2026, following positive Phase 3 GLOW2 results for Zenkuda. In December 2025, Kodiak Sciences completed a public offering of common stock, raising $184 million. The stock also hit a new 52-week high in April 2026. Despite these positive developments, the company reported missing analysts' consensus earnings per share estimates for the quarter ending March 31, 2026. Overall, the stock has shown significant increases over the past six months.